160911-12-6
160911-12-6
Chemical Structure
NCR 631
- CAS No.: 160911-12-6
- Formula:C7H5Br2NO3
- Molecular Weight:310.93
InChIKey: SEAVVBUQSYHVKP-UHFFFAOYSA-N
SMILES: O=C(C1=C(N)C(O)=C(Br)C=C1Br)O
Biological Activity: NCR 631 is a 3-HAO inhibitor and 3-hydroxyanthranilic acid (HY-W001171) analogue. NCR-631 has anticonvulsant properties. NCR-631shows a concentration-dependent protective effect against the anoxia[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
NCR 631 | 97.36% | NCR 631 is a 3-HAO inhibitor and 3-hydroxyanthranilic acid (HY-W001171) analogue. NCR-631 has anticonvulsant properties. NCR-631shows a concentration-dependent protective effect against the anoxia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Luthman J. Anticonvulsant effects of the 3-hydroxyanthranilic acid dioxygenase inhibitor NCR-631. Amino Acids. 2000;19(1):325-34. [Content Brief]
- [2]. Luthman J, et al. Effects of the 3-hydroxyanthranilic acid analogue NCR-631 on anoxia-, IL-1 beta- and LPS-induced hippocampal pyramidal cell loss in vitro. Amino Acids. 1998;14(1-3):263-9. [Content Brief]
